Advances in dilated cardiomyopathy evaluation via cardiac MRI diagnosis and prognosis: a literature review

Authors

DOI:

https://doi.org/10.51798/sijis.v5iSI1.768

Keywords:

Magnetic resonance, dilated cardiomyopathy, literature review, evidence.

Abstract

With a variety of aetiologies and clinical presentations, Dilated Cardiomyopathy (DCM) presents considerable hurdles for both diagnosis and treatment. Cardiac magnetic resonance imaging (CMR) has become a useful diagnostic technique for DCM, providing information on the anatomy, physiology, and tissue properties of the heart. Using both well-established and recently developed CMR techniques, this review investigates the function of CMR in the diagnosis and treatment of idiopathic DCM. Using reliable databases, a thorough search of the literature was carried out with an emphasis on papers released between 2014 and 2024. English-language literature examining the clinical uses of CMR in idiopathic DCM were included in the inclusion criteria. A vital component of the assessment of dilated cardiomyopathy (DCM) is cardiac magnetic resonance imaging (CMR), which provides thorough insights into the anatomy and function of the heart. Precise evaluation of tissue properties, ventricular function, and cardiac shape is made possible by CMR, which helps DCM patients get an accurate diagnosis and risk assessment. The use of advanced CMR methods, such as T1 mapping and late gadolinium enhancement (LGE) imaging, yields significant insights into the underlying aetiologies and myocardial fibrosis. Furthermore, customized prognostic evaluations are provided by CMR-based risk stratification algorithms that include many factors, improving clinical decision-making in DCM treatment. Continuous developments are expected to improve prognostic utility and accuracy, which will need efforts to lower prices and increase accessibility in order to achieve better patient outcomes and wider clinical usage

Author Biographies

Alex Fernando Abarca Real, Hospital Geriátrico Dr Bolivar Argüello P. Ecuador

Cardiologist, Chief of the Cardiology and Critical Area, Hospital Geriátrico Dr Bolivar Argüello P. Ecuador

Jessica del Rocio Flores Obregón, Hospital Geriátrico Dr Bolivar Argüello P. Ecuador

Graduate researcher. Physician, Hospital Geriátrico Dr Bolivar Argüello P. Ecuador

Magaly Morelia Sacancela Usiña, Universidad de las Américas, Ecuador

Graduate researcher. Physician, Universidad de las Américas, Ecuador

Juan José Martínez Saltos, Ministerio de Salud Pública del Ecuador

Graduate researcher. Physician, Ministerio de Salud Pública del Ecuador

Ronie Hugo Crespo Tonato, Independent graduate researcher

Independent graduate researcher. Physician, Ecuador

References

Abbasi, S. A., Ertel, A., Shah, R. V., Dandekar, V., Chung, J., Bhat, G., Desai, A. A., Kwong, R. Y., & Farzaneh-Far, A. (2013). Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients. Journal of Cardiovascular Magnetic Resonance, 15(1). https://doi.org/10.1186/1532-429X-15-89

Alba, A. C., Gaztañaga, J., Foroutan, F., Thavendiranathan, P., Merlo, M., Alonso-Rodriguez, D., Vallejo-García, V., Vidal-Perez, R., Corros-Vicente, C., Barreiro-Pérez, M., Pazos-López, P., Perez-David, E., Dykstra, S., Flewitt, J., Pérez-Rivera, J. Á., Vazquez-Caamaño, M., Katz, S. D., Sinagra, G., Køber, L., … White, J. A. (2020). Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy: An International, Multi-Institutional Study of the MINICOR Group. Circulation: Cardiovascular Imaging, 13(4), E010105. https://doi.org/10.1161/CIRCIMAGING.119.010105

Amin, R., Jones, R., Hammersley, D., gati, sabiha, Khalique, Z., Almogheer, B., Pennell, D. J., Pantazis, A., Baksi, J., Prasad, S. K., & Halliday, B. (2020). Abstract 15590: Genetic Testing and Cardiac Magnetic Resonance Imaging Results Improve Precision Stratification in Dilated Cardiomyopathy. Circulation, 142(Suppl_3). https://doi.org/10.1161/CIRC.142.SUPPL_3.15590

Antiochos, P., Ge, Y., van der Geest, R. J., Madamanchi, C., Qamar, I., Seno, A., Jerosch-Herold, M., Tedrow, U. B., Stevenson, W. G., & Kwong, R. Y. (2022). Entropy as a Measure of Myocardial Tissue Heterogeneity in Patients With Ventricular Arrhythmias. JACC: Cardiovascular Imaging, 15(5), 783–792. https://doi.org/10.1016/J.JCMG.2021.12.003

Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Arbelo, E., Barriales-Villa, R., Basso, C., Biagini, E., Blom, N. A., De Boer, R. A., De Winter, T., Perry, M. E., Flather, M., Garcia-Pavia, P., Haugaa, K. H., Ingles, J., Jurcut, R. O., Klaassen, S., Limongelli, G., … Kaski, J. P. (2023). 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). European Heart Journal, 44(37), 3503–3626. https://doi.org/10.1093/EURHEARTJ/EHAD194

Baggiano, A., Del Torto, A., Guglielmo, M., Muscogiuri, G., Fusini, L., Babbaro, M., Collevecchio, A., Mollace, R., Scafuri, S., Mushtaq, S., Conte, E., Annoni, A. D., Formenti, A., Mancini, M. E., Mostardini, G., Andreini, D., Guaricci, A. I., Pepi, M., Fontana, M., & Pontone, G. (2020). Role of CMR mapping techniques in cardiac hypertrophic phenotype. Diagnostics, 10(10). https://doi.org/10.3390/DIAGNOSTICS10100770

Becker, M. A. J., Cornel, J. H., van de Ven, P. M., van Rossum, A. C., Allaart, C. P., & Germans, T. (2018). The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis. JACC: Cardiovascular Imaging, 11(9), 1274–1284. https://doi.org/10.1016/J.JCMG.2018.03.006

Brown, P. F., Miller, C., Di Marco, A., & Schmitt, M. (2019). Towards cardiac MRI based risk stratification in idiopathic dilated cardiomyopathy. Heart, 105(4), 270–275. https://doi.org/10.1136/HEARTJNL-2018-313767

Cadour, F., Quemeneur, M., Biere, L., Donal, E., Bentatou, Z., Eicher, J. C., Roubille, F., Lalande, A., Giorgi, R., Rapacchi, S., Cortaredona, S., Tradi, F., Bartoli, A., Willoteaux, S., Delahaye, F., Biene, S. M., Mangin, L., Ferrier, N., Dacher, J. N., … Jacquier, A. (2023). Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy. Journal of Cardiovascular Magnetic Resonance, 25(1). https://doi.org/10.1186/S12968-023-00919-Y

Chan, R. H., Maron, B. J., Olivotto, I., Pencina, M. J., Assenza, G. E., Haas, T., Lesser, J. R., Gruner, C., Crean, A. M., Rakowski, H., Udelson, J. E., Rowin, E., Lombardi, M., Cecchi, F., Tomberli, B., Spirito, P., Formisano, F., Biagini, E., Rapezzi, C., … Maron, M. S. (2014). Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation, 130(6), 484–495. https://doi.org/10.1161/CIRCULATIONAHA.113.007094

Claver, E., Di Marco, A., Brown, P. F., Bradley, J., Nucifora, G., Ruiz-Majoral, A., Dallaglio, P. D., Rodriguez, M., Comin-Colet, J., Anguera, I., Miller, C. A., & Schmitt, M. (2023). Prognostic impact of late gadolinium enhancement at the right ventricular insertion points in non-ischaemic dilated cardiomyopathy. European Heart Journal Cardiovascular Imaging, 24(3), 346–353. https://doi.org/10.1093/EHJCI/JEAC109

De Angelis, G., De Luca, A., Merlo, M., Nucifora, G., Rossi, M., Stolfo, D., Barbati, G., De Bellis, A., Masè, M., Santangeli, P., Pagnan, L., Muser, D., & Sinagra, G. (2022). Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy. American Heart Journal, 246, 117–124. https://doi.org/10.1016/J.AHJ.2022.01.006

Di Marco, A., Brown, P. F., Bradley, J., Nucifora, G., Claver, E., de Frutos, F., Dallaglio, P. D., Comin-Colet, J., Anguera, I., Miller, C. A., & Schmitt, M. (2021). Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy. Journal of the American College of Cardiology, 77(23), 2890–2905. https://doi.org/10.1016/J.JACC.2021.04.030

Francone, M. (2014). Role of Cardiac Magnetic Resonance in the Evaluation of Dilated Cardiomyopathy: Diagnostic Contribution and Prognostic Significance. ISRN Radiology, 2014, 1–16. https://doi.org/10.1155/2014/365404

Gao, C., Tao, Y., Pan, J., Shen, C., Zhang, J., Xia, Z., Wan, Q., Wu, H., Gao, Y., Shen, H., Lu, Z., & Wei, M. (2019). Evaluation of elevated left ventricular end diastolic pressure in patients with preserved ejection fraction using cardiac magnetic resonance. European Radiology, 29(5), 2360–2368. https://doi.org/10.1007/S00330-018-5955-4

Guaricci, A. I., Masci, P. G., Muscogiuri, G., Guglielmo, M., Baggiano, A., Fusini, L., Lorenzoni, V., Martini, C., Andreini, D., Pavon, A. G., Aquaro, G. D., Barison, A., Todiere, G., Rabbat, M. G., Tat, E., Raineri, C., Valentini, A., Varga-Szemes, A., Schoepf, U. J., … Pontone, G. (2021). CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: An international Registry. Europace, 23(7), 1072–1083. https://doi.org/10.1093/EUROPACE/EUAA401

Halliday, B. P., Gulati, A., Ali, A., Guha, K., Newsome, S., Arzanauskaite, M., Vassiliou, V. S., Lota, A., Izgi, C., Tayal, U., Khalique, Z., Stirrat, C., Auger, D., Pareek, N., Ismail, T. F., Rosen, S. D., Vazir, A., Alpendurada, F., Gregson, J., … Prasad, S. K. (2017). Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation, 135(22), 2106–2115. https://doi.org/10.1161/CIRCULATIONAHA.116.026910

Hammersley, D. J., Jones, R. E., Owen, R., Mach, L., Lota, A. S., Khalique, Z., De Marvao, A., Androulakis, E., Hatipoglu, S., Gulati, A., Reddy, R. K., Yoon, W. Y., Talukder, S., Shah, R., Baruah, R., Guha, K., Pantazis, A., Baksi, A. J., Gregson, J., … Prasad, S. K. (2023). Phenotype, outcomes and natural history of early-stage non-ischaemic cardiomyopathy. European Journal of Heart Failure, 25(11), 2050–2059. https://doi.org/10.1002/EJHF.3037

Hammersley, D. J., Zaidi, H. A., Jones, R. E., Hatipoglu, S., Androulakis, E., Mach, L., Lota, A. S., Tayal, U., Khalique, Z., Marvao, A. De, Baruah, R., Guha, K., Pennell, D. J., Halliday, B. P., Bishop, M. J., & Prasad, S. K. (2023). 13 Myocardial fibrosis entropy is associated with life-threatening arrhythmia in non-ischaemic cardiomyopathy. Heart, 109(Suppl 1), A10–A10. https://doi.org/10.1136/HEARTJNL-2022-BSCMR.13

He, D., Ye, M., Zhang, L., & Jiang, B. (2018). Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy. Heart and Lung, 47(2), 122–126. https://doi.org/10.1016/J.HRTLNG.2017.10.008

Im, D. J., Hong, S. J., Park, E. A., Kim, E. Y., Jo, Y., Kim, J., Park, C. H., Yong, H. S., Lee, J. W., Hur, J. H., Yang, D. H., & Lee, B. Y. (2019). Guidelines for cardiovascular magnetic resonance imaging from the Korean society of cardiovascular imaging—part 3: Perfusion, delayed enhancement, and t1-and t2 mapping. Korean Journal of Radiology, 20(12), 1562–1582. https://doi.org/10.3348/KJR.2019.0411

Japp, A. G., Gulati, A., Cook, S. A., Cowie, M. R., & Prasad, S. K. (2016). The Diagnosis and Evaluation of Dilated Cardiomyopathy. Journal of the American College of Cardiology, 67(25), 2996–3010. https://doi.org/10.1016/J.JACC.2016.03.590

Kiaos, A., Antonakaki, D., Bazmpani, M. A., Karvounis, C., Rimoldi, O., & Karamitsos, T. D. (2020). Prognostic value of cardiovascular magnetic resonance T1 mapping techniques in non-ischemic dilated cardiomyopathy: A systematic review and meta-analysis. International Journal of Cardiology, 312, 110–116. https://doi.org/10.1016/J.IJCARD.2020.04.052

Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., Eiskjær, H., Brandes, A., Thøgersen, A. M., Gustafsson, F., Egstrup, K., Videbæk, R., Hassager, C., Svendsen, J. H., Høfsten, D. E., … Pehrson, S. (2016). Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. New England Journal of Medicine, 375(13), 1221–1230. https://doi.org/10.1056/NEJMOA1608029

Koutalas, E., Kanoupakis, E., & Vardas, P. (2013). Sudden cardiac death in non-ischemic dilated cardiomyopathy: A critical appraisal of existing and potential risk stratification tools. International Journal of Cardiology, 167(2), 335–341. https://doi.org/10.1016/J.IJCARD.2012.07.014

Lau, C., Gul, U., Liu, B., Captur, G., & Hothi, S. S. (2023). Cardiovascular Magnetic Resonance Imaging in Familial Dilated Cardiomyopathy. Medicina (Lithuania), 59(3), 439. https://doi.org/10.3390/MEDICINA59030439/S1

Leyva, F., Zegard, A., Okafor, O., Foley, P., Umar, F., Taylor, R. J., Marshall, H., Stegemann, B., Moody, W., Steeds, R. P., Halliday, B. P., Hammersley, D. J., Jones, R. E., Prasad, S. K., & Qiu, T. (2022). Myocardial Fibrosis Predicts Ventricular Arrhythmias and Sudden Death After Cardiac Electronic Device Implantation. Journal of the American College of Cardiology, 79(7), 665–678. https://doi.org/10.1016/J.JACC.2021.11.050

Li, S., Zhou, D., Sirajuddin, A., He, J., Xu, J., Zhuang, B., Huang, J., Yin, G., Fan, X., Wu, W., Sun, X., Zhao, S., Arai, A. E., & Lu, M. (2022). T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy: A Prognosis Study. JACC: Cardiovascular Imaging, 15(4), 578–590. https://doi.org/10.1016/J.JCMG.2021.07.023

McKenna, W. J., Maron, B. J., & Thiene, G. (2017). Classification, epidemiology, and global burden of cardiomyopathies. Circulation Research, 121(7), 722–730. https://doi.org/10.1161/CIRCRESAHA.117.309711

Merlo, M., Cannatà, A., Gobbo, M., Stolfo, D., Elliott, P. M., & Sinagra, G. (2018). Evolving concepts in dilated cardiomyopathy. European Journal of Heart Failure, 20(2), 228–239. https://doi.org/10.1002/EJHF.1103

Neubauer, S., Kolm, P., Ho, C. Y., Kwong, R. Y., Desai, M. Y., Dolman, S. F., Appelbaum, E., Desvigne-Nickens, P., DiMarco, J. P., Friedrich, M. G., Geller, N., Harper, A. R., Jarolim, P., Jerosch-Herold, M., Kim, D. Y., Maron, M. S., Schulz-Menger, J., Piechnik, S. K., Thomson, K., … Kramer, C. M. (2019). Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry. Journal of the American College of Cardiology, 74(19), 2333–2345. https://doi.org/10.1016/J.JACC.2019.08.1057

Perone, F., Dentamaro, I., La Mura, L., Alifragki, A., Marketou, M., Cavarretta, E., Papadakis, M., & Androulakis, E. (2024). Current Insights and Novel Cardiovascular Magnetic Resonance-Based Techniques in the Prognosis of Non-Ischemic Dilated Cardiomyopathy. Journal of Clinical Medicine 2024, Vol. 13, Page 1017, 13(4), 1017. https://doi.org/10.3390/JCM13041017

Pirruccello, J. P., Bick, A., Wang, M., Chaffin, M., Friedman, S., Yao, J., Guo, X., Venkatesh, B. A., Taylor, K. D., Post, W. S., Rich, S., Lima, J. A. C., Rotter, J. I., Philippakis, A., Lubitz, S. A., Ellinor, P. T., Khera, A. V., Kathiresan, S., & Aragam, K. G. (2020). Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy. Nature Communications, 11(1). https://doi.org/10.1038/S41467-020-15823-7

Porcari, A., De Angelis, G., Romani, S., Paldino, A., Artico, J., Cannatà, A., Gentile, P., Pinamonti, B., Merlo, M., & Sinagra, G. (2019). Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques. Expert Review of Cardiovascular Therapy, 17(1), 53–63. https://doi.org/10.1080/14779072.2019.1550719

Priori, S. G., Blomstrom-Lundqvist, C., Mazzanti, A., Bloma, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., Kirchhof, P., Kjeldsen, K., Kuck, K. H., Hernandez-Madrid, A., Nikolaou, N., Norekval, T. M., Spaulding, C., Van Veldhuisen, D. J., Kolh, P., … Parkhomenko, A. (2015). 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). European Heart Journal, 36(41), 2793-2867l. https://doi.org/10.1093/EURHEARTJ/EHV316

Rubiś, P. P., Dziewięcka, E. M., Banyś, P., Urbańczyk-Zawadzka, M., Krupiński, M., Mielnik, M., Łach, J., Ząbek, A., Wiśniowska-Śmiałek, S., Podolec, P., Karabinowska, A., Holcman, K., & Garlitski, A. C. (2021). Extracellular volume is an independent predictor of arrhythmic burden in dilated cardiomyopathy. Scientific Reports, 11(1). https://doi.org/10.1038/S41598-021-03452-Z

Schultheiss, H. P., Fairweather, D. L., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., & Priori, S. G. (2019). Dilated cardiomyopathy. Nature Reviews Disease Primers, 5(1). https://doi.org/10.1038/S41572-019-0084-1

Te Rijdt, W. P., Ten Sande, J. N., Gorter, T. M., Van Der Zwaag, P. A., Van Rijsingen, I. A., Boekholdt, S. M., Van Tintelen, J. P., Van Haelst, P. L., Planken, R. N., De Boer, R. A., Suurmeijer, A. J. H., Van Veldhuisen, D. J., Wilde, A. A. M., Willems, T. P., Van Dessel, P. F. H. M., & Van Den Berg, M. P. (2019). Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging. European Heart Journal - Cardiovascular Imaging, 20(1), 92–100. https://doi.org/10.1093/EHJCI/JEY047

Valbuena-López, S., Hinojar, R., & Puntmann, V. O. (2016). Resonancia magnética cardiovascular en la práctica cardiológica: una guía concisa para la adquisición de imágenes y la interpretación clínica. Revista Espanola de Cardiologia, 69(2), 202–210. https://doi.org/10.1016/J.RECESP.2015.11.012

Vita, T., Gräni, C., Abbasi, S. A., Neilan, T. G., Rowin, E., Kaneko, K., Coelho-Filho, O., Watanabe, E., Mongeon, F. P., Farhad, H., Rassi, C. H., Choi, Y. L., Cheng, K., Givertz, M. M., Blankstein, R., Steigner, M., Aghayev, A., Jerosch-Herold, M., & Kwong, R. Y. (2019). Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy. JACC: Cardiovascular Imaging, 12(8P2), 1659–1669. https://doi.org/10.1016/J.JCMG.2018.08.021

Vitrella, G., Faganello, G., Morea, G., Pagnan, L., Belgrano, M., & Cova, M. A. (2019). Role of Cardiac Imaging: Cardiac Magnetic Resonance and Cardiac Computed Tomography. Dilated Cardiomyopathy: From Genetics to Clinical Management, 113–133. https://doi.org/10.1007/978-3-030-13864-6_8

Xu, J., Zhuang, B., Sirajuddin, A., Li, S., Huang, J., Yin, G., Song, L., Jiang, Y., Zhao, S., & Lu, M. (2020). MRI T1 mapping in hypertrophic cardiomyopathy: Evaluation in patients without late gadolinium enhancement and hemodynamic obstruction. Radiology, 294(2), 275–286. https://doi.org/10.1148/RADIOL.2019190651

Downloads

Published

2024-05-21

How to Cite

Abarca Real, A. F., Flores Obregón, J. del R., Sacancela Usiña, M. M., Martínez Saltos, J. J., & Crespo Tonato, R. H. (2024). Advances in dilated cardiomyopathy evaluation via cardiac MRI diagnosis and prognosis: a literature review. Sapienza: International Journal of Interdisciplinary Studies, 5(SI1), e24S07. https://doi.org/10.51798/sijis.v5iSI1.768